Geode Capital Management LLC Increases Stock Holdings in HealthEquity, Inc. $HQY

Geode Capital Management LLC increased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,201,232 shares of the company’s stock after purchasing an additional 5,671 shares during the period. Geode Capital Management LLC owned 2.58% of HealthEquity worth $201,685,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in HQY. Sivia Capital Partners LLC purchased a new stake in shares of HealthEquity in the second quarter valued at $306,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of HealthEquity in the second quarter valued at $4,747,000. Marshall Wace LLP purchased a new stake in shares of HealthEquity in the second quarter valued at $5,483,000. Amundi grew its position in shares of HealthEquity by 9.3% in the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after purchasing an additional 2,574 shares during the period. Finally, Jump Financial LLC purchased a new stake in shares of HealthEquity in the second quarter valued at $449,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on HQY shares. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Monday. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research report on Thursday, February 19th. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. Wells Fargo & Company set a $111.00 price target on HealthEquity in a research report on Monday. Finally, Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $111.53.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 13,081 shares of company stock valued at $1,193,000. Company insiders own 1.60% of the company’s stock.

HealthEquity Price Performance

HQY stock opened at $88.34 on Wednesday. The stock has a 50-day moving average price of $83.63 and a two-hundred day moving average price of $86.61. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market cap of $7.39 billion, a PE ratio of 33.09, a price-to-earnings-growth ratio of 1.55 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 3.84 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.